Prophylactic anticoagulation of individuals with Proteus syndrome and COVID-19.

Ours, Christopher A; Biesecker, Leslie G

Ours, Christopher A; Biesecker, Leslie G.

Ours CA; Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Biesecker LG; Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.

Am J Med Genet A ; 182(12): 2829-2831, 2020 12.

Article in English | MEDLINE | ID: covidwho-1575215

Subject(s)

Anticoagulants/administration & dosage; COVID-19 Drug Treatment; Proteus Syndrome/drug therapy; Blood Coagulation; COVID-19/complications; Humans; Post-Exposure Prophylaxis; Proteus Syndrome/complications

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Proteus Syndrome / COVID-19 Drug Treatment / Anticoagulants Topics: Long Covid Limits: Humans Language: English Journal: Am J Med Genet A Journal subject: Genetics, Medical Year: 2020 Document Type: Article Affiliation country: Ajmg.a.61861

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google